{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/25/3350195/0/en/molecular-partners-reports-h1-2026-financial-results-and-corporate-highlights-dll3-radiotherapy-mp0712-successfully-advancing-to-higher-dose-level-in-phase-1-2a-study.html", "message": "News view counter 900502 successfully enlarged"}